duocarmycin sa has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baraldi, PG; Boger, DL; Hwang, I; MacMillan, KS; Pavani, MG; Rayl, TJ; Spalluto, G; Stover, JS; Tichenor, MS; Wolkenberg, SE; Zaid, AN; Zanella, L | 1 |
| Lee, M; Pradel, G; Purcell, LA; Rodriguez, A; Sato, A; Spithill, TW; Yanow, SK | 1 |
2 other study(ies) available for duocarmycin sa and Disease Models, Animal
| Article | Year |
|---|---|
Rational design, synthesis, and evaluation of key analogues of CC-1065 and the duocarmycins.
Topics: Alkylation; Animals; Antiparasitic Agents; Cell Line, Tumor; Combinatorial Chemistry Techniques; Disease Models, Animal; DNA; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Design; Duocarmycins; Indoles; Injections, Intraperitoneal; Mice; Mice, Inbred DBA; Molecular Structure; Pyrroles; Stereoisomerism; Survival Rate; Xenograft Model Antitumor Assays | 2007 |
Potent antimalarial and transmission-blocking activities of centanamycin, a novel DNA-binding agent.
Topics: Alkylating Agents; Animals; Anopheles; Antimalarials; Disease Models, Animal; Duocarmycins; Female; Indoles; Mice; Oocysts; Plasmodium; Pyrroles; Sporozoites | 2008 |